Richard Ferrari , MBA

Director

De Novo Ventures
Saratoga, CA

Richard Ferrari is a managing director at De Novo Ventures, a healthcare investment firm offering advice, guidance, and feedback to the current generation of medical device entrepreneurs. Mr Ferrari is also a Co-Founder of De Novo. Additionally, Mr. Ferrari has been a successful CEO of two publicly traded medical technology companies: Cardiovascular Imaging Systems (acquired by Boston Scientific) and CardioThoracic Systems (acquired by Guidant). Cardiovascular Imaging Systems is the leader in ultrasound imaging catheters and CTS is the market leader in disposable instruments and systems for performing minimally invasive beating heart bypass surgery. Mr. Ferrari was also a Co-Founder of CTS, contributing to the company's initial public offering in only seven months. Furthermore, Mr. Ferrari also Co-Founded the Medical technology Group which spun-out Integrated Vascular Systems, later acquired by Abbot Vascular and Ensure, acquired by Johnson & Johnson. Mr. Ferrari serves as a faculty member of the Stanford Biodesign Emerging Entrepreneurs Forum in addition to being a board member of the Stanford Coulter Foundation for Translational Medicine. Ferrari also held positions such as the Executive Vice President and General Manager of ADAC Laboratories. In 1996, he founded Saratoga Ventures, a venture capital partnership that provided financing to startup medical technology companies. Mr. Ferrari received his B.S. degree from Ashland College and later an M.B.A from the University of South Florida. He is also the recipient of the Mallinckrodt Award for Excellence in medicine.